News
News releases on November 12, 2021, page 4
Every news release public companies put out on November 12, 2021 (UTC): 479 news releases, newest first. Open any release to read it.
PepsiCo Announces Two Senior Leadership Appointments to Drive Accelerated Growth
PepsiCo, Inc. · Nov 12, 2021
Papa John’s Shaq-a-Roni Pizza with a Purpose Raises More than $3 Million for The Papa John’s Foundation for the Second Year
Papa John's International, Inc. · Nov 12, 2021
Oxbridge Re Holdings Limited Reports Strong Performance for First Nine Months of 2021
Oxbridge Re Holdings Limited · Nov 12, 2021
Origin Agritech's Next-Generation GMO Corn Trait Advances in Approval Process
Origin Agritech Limited · Nov 12, 2021
OLB Group Inc. Reports Third Quarter, 2021 Revenues of $2.82 Million
The OLB Group, Inc. · Nov 12, 2021
Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference
Nurix Therapeutics, Inc. · Nov 12, 2021
Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a var...
Nurix Therapeutics, Inc. · Nov 12, 2021
Northern Lights Resources Commences Drilling at Tin Cup Prospect, Arizona
Northern Lights Resources Corp · Nov 12, 2021
Nordson Releases Environmental, Social and Governance Report
Nordson Corporation · Nov 12, 2021
Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
Nkarta, Inc. · Nov 12, 2021
Nevada Lithium Resources Announces $8.0 Million Brokered Private Placement
Nevada Lithium Resources, Inc. · Nov 12, 2021
Neoleukin Therapeutics Presents NL-201 Preclinical Data at Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Neurogene Inc. · Nov 12, 2021
Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at the 2021 Society for Immunotherapy of Cancer (SITC) ...
Nektar Therapeutics · Nov 12, 2021
Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
Mustang Bio, Inc. · Nov 12, 2021
Monopar Therapeutics Reports Third Quarter 2021 Financial Results and Recent Clinical Developments
Monopar Therapeutics Inc. · Nov 12, 2021
Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Triplet Program at 2021 SITC Annual Meeting
Moderna, Inc. · Nov 12, 2021
MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797
MiNK Therapeutics, Inc. · Nov 12, 2021
Millicom (Tigo) closes Guatemala transaction
Millicom International Cellular S.A. · Nov 12, 2021
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
Milestone Pharmaceuticals Inc. · Nov 12, 2021
Meten Holding Group Ltd. Closes $20 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market Under Nasdaq Rules
BTC Digital Ltd. · Nov 12, 2021
Melkior Resources Reports Results from 2021 Drill Program at Val D'or Project
Melkior Resources Inc. · Nov 12, 2021
Mannatech Reports Third Quarter End 2021 Financial Results
Mannatech, Incorporated · Nov 12, 2021
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
Lyell Immunopharma, Inc. · Nov 12, 2021
Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Longeveron Inc. · Nov 12, 2021
LivaNova Comments on Decision by Court of Appeal of Milan
LivaNova PLC · Nov 12, 2021
Leopard Lake Gold Closes $0.10 Non-Brokered Private Placement
Leopard Lake Gold Corp. · Nov 12, 2021
LENSAR Announces Poster Presentations at the American Academy of Ophthalmology
LENSAR, Inc. · Nov 12, 2021
Lattice Named CES 2022 Innovation Awards Honoree
Lattice Semiconductor Corporation · Nov 12, 2021
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
Larimar Therapeutics, Inc. · Nov 12, 2021
Kymera Therapeutics Presents New Preclinical Data on STAT3 Degraders at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Kymera Therapeutics, Inc. · Nov 12, 2021
Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
Jasper Therapeutics, Inc. · Nov 12, 2021
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) An...
Iovance Biotherapeutics, Inc. · Nov 12, 2021
Ionis' antisense therapies to be featured at the American Heart Association (AHA) Scientific Sessions 2021
Ionis Pharmaceuticals, Inc. · Nov 12, 2021
InnovAge Appoints Patrick Blair as President
InnovAge Holding Corp. · Nov 12, 2021
Independent Bank Corp. and Rockland Trust Complete Meridian Bancorp, Inc. and East Boston Savings Bank Acquisition
Independent Bank Corp. · Nov 12, 2021
Immunovant to Present at the Stifel 2021 Virtual Healthcare Conference
Immunovant, Inc. · Nov 12, 2021
IBEX Limited to Announce First Quarter Fiscal Year 2022 Financial Results on November 22, 2021
IBEX Limited · Nov 12, 2021
Hycroft Files 2021 Third Quarter 10-Q And Reports Financial Results
Hycroft Mining Holding Corporation · Nov 12, 2021
Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
Humacyte, Inc. · Nov 12, 2021
Hooker Furnishings to Host Third Quarter Earnings Call December 9th
Hooker Furnishings Corporation · Nov 12, 2021
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise...
Solana Company · Nov 12, 2021
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
HCW Biologics Inc. · Nov 12, 2021
Gulf Resources Announces Conference Call to Discuss Third Quarter 2021 Results
Gulf Resources, Inc. · Nov 12, 2021
GreenPower Reports Fiscal Second Quarter 2022 Financial Results
GreenPower Motor Company Inc. · Nov 12, 2021
Great Elm Group Reports Fiscal 2022 First Quarter Financial Results
Great Elm Group, Inc. · Nov 12, 2021
Great Elm Group Reports Fiscal 2022 First Quarter Financial Results
Great Elm Capital Corp. · Nov 12, 2021
Golden Independence Mining and Hilo Mining Complete Spin-Out
Nexus Uranium Corp · Nov 12, 2021
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
Geron Corporation · Nov 12, 2021
Gemini Therapeutics Announces Poster Presentation at AAO 2021
Disc Medicine, Inc. · Nov 12, 2021
Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update
Gain Therapeutics, Inc. · Nov 12, 2021
Flux Power Announces Financial Results for First Quarter of FY 2022; Revenue of $6.3M, an Increase of 39% YOY
Flux Power Holdings, Inc. · Nov 12, 2021
FitLife Brands Announces Third Quarter 2021 Results
FitLife Brands, Inc. · Nov 12, 2021
Farmers National Banc Corp. Prices Private Placement of $75 Million of Subordinated Notes
Farmers National Banc Corp. · Nov 12, 2021
Ero Copper Files Technical Report for Boa Esperança Project
Ero Copper Corp. · Nov 12, 2021
Energy Focus, Inc. Reports Third Quarter 2021 Financial Results
Energy Focus, Inc. · Nov 12, 2021
Enanta Pharmaceuticals Reports Positive Final Data from its Phase 1b Studies of EDP-514, a Novel Hepatitis B Virus Core Inhibitor
Enanta Pharmaceuticals, Inc. · Nov 12, 2021
Editas Medicine Presents Preclinical Data on Novel Engineered iPSC-derived NK Cells for the Treatment of Cancer at the Society for Immuno...
Editas Medicine, Inc. · Nov 12, 2021
Eastern Bankshares, Inc. Announces Completion Of Merger With Century Bancorp, Inc.
Eastern Bankshares, Inc. · Nov 12, 2021
DraftKings Sportsbook at Foxwoods Resort Casino Opens November 13
DraftKings Inc. · Nov 12, 2021
Dermata Announces Presentation Details for Its DMT410 Phase 1b Proof of Concept Aesthetic Study at The American Society for Dermatologic ...
Dermata Therapeutics, Inc. · Nov 12, 2021
Cue Biopharma Presents Updated Data from Lead Program CUE-101 for the Treatment of Recurrent/Metastatic HPV+ Head and Neck Cancer and Add...
Cue Biopharma, Inc. · Nov 12, 2021
Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial at the 2021 Society for Immunotherapy...
Corvus Pharmaceuticals, Inc. · Nov 12, 2021
Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Corbus Pharmaceuticals Holdings, Inc. · Nov 12, 2021
Contango ORE Announces Results of the 2021 Virtual Annual Meeting of Stockholders and Results for the Quarter Ended September 30, 2021
Contango Silver & Gold Inc. · Nov 12, 2021
Compugen Reports Third Quarter 2021 Results
Compugen Ltd. · Nov 12, 2021
Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of COM902 a High Affinity Anti-TIGIT Antibody at SIT...
Compugen Ltd. · Nov 12, 2021
Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 with Opdivo® and BMS-986207 (Anti-TIGIT Antibody) at...
Compugen Ltd. · Nov 12, 2021
Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1 as a Novel Checkpoint on ...
Compugen Ltd. · Nov 12, 2021
Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Compass Therapeutics, Inc. · Nov 12, 2021
ClearOne, Inc. Reports Third Quarter 2021 Financial Results
ClearOne, Inc. · Nov 12, 2021
Cipher Mining Provides Third Quarter 2021 Business Update
Cipher Digital Inc. · Nov 12, 2021
China Automotive Systems Reports Unaudited 2021 Third Quarter Results
China Automotive Systems, Inc. · Nov 12, 2021
Cerence to Announce Fourth Quarter and Full Fiscal Year Results on November 22, 2021
Cerence Inc. · Nov 12, 2021
Cemtrex Regains Compliance with Nasdaq Audit Committee Composition Requirements & Appoints Two New Independent Directors to Its Board of ...
Cemtrex Inc. · Nov 12, 2021
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
Celularity Inc. · Nov 12, 2021
Celldex Presents Positive Preclinical Data from PD-1/ILT4 Bispecific Antibody Program CDX-585 at SITC 2021
Celldex Therapeutics, Inc. · Nov 12, 2021
CBAK Energy Reports Third Quarter 2021 Unaudited Financial Results
CBAK Energy Technology, Inc. · Nov 12, 2021
Catalyst Biosciences Announces Change in Corporate Strategy
Gyre Therapeutics, Inc. · Nov 12, 2021
Candel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
Candel Therapeutics, Inc. · Nov 12, 2021
Candel Therapeutics Presents Novel Biomarker Data Demonstrating Immune Activation After Administration of CAN-3110 in Patients with Recur...
Candel Therapeutics, Inc. · Nov 12, 2021
Cadence Wins Four 2021 TSMC OIP Partner of the Year Awards, Featuring Key Advancements in 3DFabric Design and Cloud-Based Solutions
Cadence Design Systems, Inc. · Nov 12, 2021
BT Brands, Inc. Announces Pricing of Upsized $12 Million Initial Public Offering
BT Brands, Inc. · Nov 12, 2021
Broadway Financial Corporation Reports Results for the Third Quarter of 2021
Broadway Financial Corporation · Nov 12, 2021
Brilliant Earth Reports Outstanding Third Quarter 2021 Results
Brilliant Earth Group, Inc. · Nov 12, 2021
Booking Holdings Enters Into Agreement To Acquire Getaroom
Booking Holdings Inc. Common Stock · Nov 12, 2021
Beam Therapeutics Reports Preclinical Data Highlighting Multiplex Base Editing Approach to Create Anti-CD5 CAR T-cell Investigational The...
Beam Therapeutics Inc. · Nov 12, 2021
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
AtriCure, Inc. · Nov 12, 2021
Atlanticus Reports Third Quarter 2021 Financial Results
Atlanticus Holdings Corporation · Nov 12, 2021
Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation · Nov 12, 2021
Assertio Holdings, Inc. Announces Preliminary Court Approval of Shareholder Derivative Settlement
Assertio Holdings, Inc. · Nov 12, 2021
Assembly Biosciences Presents New Data at AASLD The Liver Meeting™ Highlighting the Progress of its HBV Core Inhibitor Portfolio
Assembly Biosciences, Inc. · Nov 12, 2021
Arrowhead Presents Additional Clinical Data on Investigational ARO-HSD Treatment at AASLD Liver Meeting
Arrowhead Pharmaceuticals, Inc. · Nov 12, 2021
Arrowhead Presents Additional Clinical Data on Investigational ARO-AAT Treatment at AASLD Liver Meeting
Arrowhead Pharmaceuticals, Inc. · Nov 12, 2021
Ares Capital Corporation to Present at Fitch Ratings BDC Conference 2021
Ares Capital Corporation · Nov 12, 2021
Ardelyx Reports Third Quarter 2021 Financial Results
Ardelyx, Inc. · Nov 12, 2021
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
Aptevo Therapeutics Inc. · Nov 12, 2021
Apellis Reiterates Plans to Submit a New Drug Application in the First Half of 2022 for Pegcetacoplan for Geographic Atrophy Following FD...
Apellis Pharmaceuticals, Inc. · Nov 12, 2021
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update
Nov 12, 2021
Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Allogene Therapeutics, Inc. · Nov 12, 2021
Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer’s 36th Annual Meeting
Alector, Inc. · Nov 12, 2021